20:29 , Oct 5, 2018 |  BC Week In Review  |  Financial News

Owlstone adds $35M to $50M series C

Early disease detection and precision medicine company Owlstone Medical Ltd. (Cambridge, U.K.) raised $35 million led by Horizons Ventures as part of its untranched series C round. The sum brings the total in the round...
17:57 , Sep 7, 2018 |  BC Week In Review  |  Financial News

Winter, Jackson, Ramakishnan, Balasubramaniam among co-founders of new U.K. fund Ahren

Ahren Innovation Capital LLP (Cambridge, U.K.) announced the first close of its Ahren LP fund with over $100 million from Aviva, Wittington Investments and undisclosed U.S. family offices. The fund declined to disclose the exact...
23:29 , Sep 4, 2018 |  BC Extra  |  Financial News

Winter, Jackson, Ramakishnan, Balasubramaniam among co-founders of new U.K. fund Ahren

Ahren Innovation Capital LLP (Cambridge, U.K.) announced the first close of its Ahren LP fund with over $100 million from Aviva, Wittington Investments and undisclosed U.S. family offices. The fund declined to disclose the exact...
00:10 , Jul 18, 2015 |  BC Extra  |  Company News

QIDP for Motif's iclaprim triggers L22M placing

FDA granted Qualified Infectious Disease Product (QIDP) designation to iclaprim from Motif Bio plc (LSE:MTFB) to treat hospital-acquired bacterial pneumonia (HABP), triggering a L22 million ($34.1 million) placing. Motif sold 44 million shares at 50p...
07:00 , May 11, 2015 |  BC Week In Review  |  Financial News

Newron completes private placement

Newron Pharmaceuticals S.p.A. (SIX:NWRN), Bresso, Italy   Business: Neurology   Date completed: 2015-04-30   Type: Private placement   Raised: CHF24.3 million ($25.9 million)   Shares: 843,072   Price: CHF28.80   Shares after offering: 13.9 million...
07:00 , Oct 27, 2014 |  BC Week In Review  |  Financial News

ImmuPharma completes private placement

ImmuPharma plc (LSE:IMM), London, U.K.   Business: Autoimmune, Neurology, Infectious   Date completed: 2014-10-21   Type: Private placement   Raised: L3.4 million ($5.4 million)   Shares: 6.3 million   Price: 53p   Shares after offering:...
07:00 , Apr 14, 2014 |  BC Week In Review  |  Financial News

Newron completes private placement

Newron Pharmaceuticals S.p.A. (SIX:NWRN), Bresso, Italy   Business: Neurology   Date completed: 4/7/14   Type: Private placement   Raised: CHF18.6 million ($20.9 million)   Shares: 1.2 million   Price: CHF15.75   Shares after offering: 13...
08:00 , Jan 9, 2014 |  BC Innovations  |  Distillery Techniques

Technology: Disease models

Approach Summary Licensing status Publication and contact information Disease models Dorsal root ganglion (DRG) neurons from transgenic mice expressing human microtubule-associated protein-t (MAPT; tau; FTDP-17) P301S recapitulate tau pathology in vitro A cell culture model...
08:00 , Feb 18, 2013 |  BioCentury  |  Finance

Expanding network

Expanding network When e-Therapeutics plc (LSE:ETX) closes its £40 million ($63 million) placing, the money will nearly match the company's £42.5 million market cap at the time the deal was announced and surpass the total...
07:00 , Sep 8, 2011 |  BC Innovations  |  Tools & Techniques

A sweet sensor

Researchers at the University of Illinois at Urbana-Champaign have developed DNA sensors that can be used with commercially available personal glucose meters to detect and quantify compounds other than glucose. 1 The researchers are now...